Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells.

Tsitoura E, Wells AU, Karagiannis K, Lasithiotaki I, Vasarmidi E, Bibaki E, Koutoulaki C, Sato H, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM.

Oncotarget. 2016 Nov 15;7(46):74569-74581. doi: 10.18632/oncotarget.12740.

2.

miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.

Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N, Antoniou KM.

Mol Med Rep. 2018 May;17(5):7105-7112. doi: 10.3892/mmr.2018.8778. Epub 2018 Mar 19.

3.

miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1.

Li S, Geng J, Xu X, Huang X, Leng D, Jiang D, Liang J, Wang C, Jiang D, Dai H.

PLoS One. 2016 Mar 8;11(3):e0150418. doi: 10.1371/journal.pone.0150418. eCollection 2016.

4.

miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.

Liang H, Liu S, Chen Y, Bai X, Liu L, Dong Y, Hu M, Su X, Chen Y, Huangfu L, Li X, Gu Y, Shan H.

J Mol Med (Berl). 2016 Jun;94(6):655-65. doi: 10.1007/s00109-016-1381-8. Epub 2016 Jan 20.

PMID:
26787543
5.

Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.

Kamikawaji K, Seki N, Watanabe M, Mataki H, Kumamoto T, Takagi K, Mizuno K, Inoue H.

J Hum Genet. 2016 Dec;61(12):985-993. doi: 10.1038/jhg.2016.99. Epub 2016 Aug 4.

PMID:
27488440
6.

Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.

Yang G, Yang L, Wang W, Wang J, Wang J, Xu Z.

Gene. 2015 May 10;562(1):138-44. doi: 10.1016/j.gene.2015.02.065. Epub 2015 Feb 25.

PMID:
25725128
7.

miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.

Zhang Q, Ye H, Xiang F, Song LJ, Zhou LL, Cai PC, Zhang JC, Yu F, Shi HZ, Su Y, Xin JB, Ma WL.

Mol Ther. 2017 Mar 1;25(3):728-738. doi: 10.1016/j.ymthe.2016.12.017. Epub 2017 Jan 26.

8.

MicroRNAs in idiopathic pulmonary fibrosis.

Pandit KV, Milosevic J, Kaminski N.

Transl Res. 2011 Apr;157(4):191-9. doi: 10.1016/j.trsl.2011.01.012. Epub 2011 Feb 4. Review.

PMID:
21420029
9.

Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.

Giménez A, Duch P, Puig M, Gabasa M, Xaubet A, Alcaraz J.

Int J Mol Sci. 2017 Nov 16;18(11). pii: E2431. doi: 10.3390/ijms18112431.

10.

Pathologic Regulation of Collagen I by an Aberrant Protein Phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 Signal Axis in Idiopathic Pulmonary Fibrosis Fibroblasts.

Khalil W, Xia H, Bodempudi V, Kahm J, Hergert P, Smith K, Peterson M, Parker M, Herrera J, Bitterman PB, Henke CA.

Am J Respir Cell Mol Biol. 2015 Sep;53(3):391-9. doi: 10.1165/rcmb.2014-0150OC.

11.

MicroRNA-29a regulates lipopolysaccharide (LPS)-induced inflammatory responses in murine macrophages through the Akt1/ NF-κB pathway.

Tang B, Li X, Ren Y, Wang J, Xu D, Hang Y, Zhou T, Li F, Wang L.

Exp Cell Res. 2017 Nov 15;360(2):74-80. doi: 10.1016/j.yexcr.2017.08.013. Epub 2017 Aug 12.

PMID:
28811129
12.

The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.

Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, Li T, Li X, Liu Y, Huangfu L, Lu Y, Zhang Z, Yang B, Gitau S, Lu Y, Shan H, Du Z.

Mol Ther. 2014 Jun;22(6):1122-1133. doi: 10.1038/mt.2014.42. Epub 2014 Mar 5.

13.
14.

Inhibition and role of let-7d in idiopathic pulmonary fibrosis.

Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N.

Am J Respir Crit Care Med. 2010 Jul 15;182(2):220-9. doi: 10.1164/rccm.200911-1698OC. Epub 2010 Apr 15.

15.

MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix.

Nho RS, Im J, Ho YY, Hergert P.

Am J Physiol Lung Cell Mol Physiol. 2014 Oct 15;307(8):L632-42. doi: 10.1152/ajplung.00127.2014. Epub 2014 Aug 29.

16.

Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.

Li ZJ, Ou-Yang PH, Han XP.

Cell Signal. 2014 Jan;26(1):141-8. doi: 10.1016/j.cellsig.2013.09.018. Epub 2013 Oct 4.

PMID:
24100264
17.

The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.

Kurowska-Stolarska M, Hasoo MK, Welsh DJ, Stewart L, McIntyre D, Morton BE, Johnstone S, Miller AM, Asquith DL, Millar NL, Millar AB, Feghali-Bostwick CA, Hirani N, Crick PJ, Wang Y, Griffiths WJ, McInnes IB, McSharry C.

J Allergy Clin Immunol. 2017 Jun;139(6):1946-1956. doi: 10.1016/j.jaci.2016.09.021. Epub 2016 Oct 14.

18.

Downregulation of microRNA‑30a in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients.

Liu B, Jiang T, Hu X, Liu Z, Zhao L, Liu H, Liu Z, Ma L.

Mol Med Rep. 2018 Dec;18(6):5799-5806. doi: 10.3892/mmr.2018.9565. Epub 2018 Oct 18.

PMID:
30365083
19.

Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.

Milara J, Navarro R, Juan G, Peiró T, Serrano A, Ramón M, Morcillo E, Cortijo J.

Thorax. 2012 Feb;67(2):147-56. doi: 10.1136/thoraxjnl-2011-200026. Epub 2011 Nov 21.

PMID:
22106015
20.

Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function.

Zhou C, Zou QY, Li H, Wang RF, Liu AX, Magness RR, Zheng J.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3470-3479. doi: 10.1210/jc.2017-00849.

Supplemental Content

Support Center